C. Liebmann

发表

Bradykinin Signalling to MAP Kinase: Cell-Specific Connections versus Principle Mitogenic Pathways

C. Liebmann, 2001, Biological chemistry.

Pharmacological and molecular actions of the bradykinin B2 receptor antagonist, Hoe 140, in the rat uterus.

C. Liebmann, S. Nawrath, B. Ludwig, 1993, European journal of pharmacology.

Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells.

A. Berndt, M. Franz, C. Liebmann, 2014, Experimental cell research.

Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes

K. Jakobs, M. Schnittler, H. Schubert, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

High-affinity bradykinin receptor-catalyzed G protein activation in rat myometrium.

K. Jakobs, M. Schnittler, C. Liebmann, 1991, European journal of pharmacology.

Bradykinin B2 Receptor-Mediated Mitogen-Activated Protein Kinase Activation in COS-7 Cells Requires Dual Signaling via Both Protein Kinase C Pathway and Epidermal Growth Factor Receptor Transactivation

R. Wetzker, K. Seedorf, C. Liebmann, 1999, Molecular and Cellular Biology.

A Novel Mitogenic Signaling Pathway of Bradykinin in the Human Colon Carcinoma Cell Line SW-480 Involves Sequential Activation of a Gq/11 Protein, Phosphatidylinositol 3-Kinase β, and Protein Kinase Cε*

R. Wetzker, C. Liebmann, A. Graness, 1998, The Journal of Biological Chemistry.

Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.

P. Presek, C. Liebmann, A. Graness, 2000, The Biochemical journal.

In various tumour cell lines the peptide bradykinin B2 receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist

C. Liebmann, S. Drube, 2000, British journal of pharmacology.

Potent photoaffinity labelled and iodinated antagonists of bradykinin.

S. Reissmann, T. Steinmetzer, C. Schumann, 1995, Biological chemistry Hoppe-Seyler.

Syntheses and properties of new agonists and antagonists of bradykinin

S. Reissmann, K. Wiesmüller, G. Greiner, 1993 .

The adenylate cyclase-inhibiting bradykinin receptor in guinea pig ileum membranes exhibits an unique antagonist profile.

C. Liebmann, S. Nawrath, A. Graness, 1995, European journal of pharmacology.

A high-affinity bradykinin receptor in membranes from rat myometrium is coupled to pertussis toxin-sensitive G-proteins of the Gi family.

G. Schultz, S. Reissmann, S. Offermanns, 1990, Biochemical and biophysical research communications.

Signaling effects of α‐thrombin and SFLLRN in rat glioma C6 cells

P. Henklein, H. Haller, C. Lindschau, 1996 .

Bradykinin inhibits adenylate cyclase activity in guinea pig ileum membranes via a separate high-affinity bradykinin B2 receptor.

C. Liebmann, A. Graness, K. Mammery, 1994, European journal of pharmacology.

Tyr‐c[D‐Orn‐Tyr(Bzl)‐Pro‐Gly]: a novel antiproliferative acting somatostatin receptor agonist with μ‐opioid receptor‐sensitizing properties

U. Stürzebecher, K. Neubert, F. Böhmer, 2003, British journal of pharmacology.

Antagonist binding reveals two heterogenous B2 bradykinin receptors in rat myometrial membranes.

J. Stewart, S. Reissmann, M. Schnittler, 1991, European journal of pharmacology.

Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin.

V. Brantl, C. Liebmann, U. Schrader, 1989, European journal of pharmacology.

[3H]naloxone as an opioid receptor label: analysis of binding site heterogeneity and use for determination of opioid affinities of casomorphin analogues.

H. Repke, M. Schnittler, K. Neubert, 1990, Biomedica biochimica acta.

Cross Talk between β-Adrenergic and Bradykinin B2Receptors Results in Cooperative Regulation of Cyclic AMP Accumulation and Mitogen-Activated Protein Kinase Activity

C. Liebmann, S. Hanke, D. Groll, 2001, Molecular and Cellular Biology.

Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity.

C. Liebmann, Claus Liebmann, 2001, Cellular signalling.

A method for the isolation of plasma membranes from rat uterus and rat duodenum

S. Reissmann, R. Reissmann, C. Liebmann, 1976 .

New photoaffinity labelled agonists of bradykinin.

S. Reissmann, T. Steinmetzer, C. Schumann, 1995, Biological chemistry Hoppe-Seyler.

Nonopioid effects of β-casomorphin-5 in guinea pig heart: Alterations to the β-adrenoceptor-G-protein complex and inhibition of myocardial responses to isoproterenol

M. Schnittler, K. Neubert, C. Liebmann, 1991, Peptides.

EGF receptor activation by GPCRs: An universal pathway reveals different versions

C. Liebmann, 2011, Molecular and Cellular Endocrinology.

Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling.

C. Valkova, C. Liebmann, S. Drube, 2006, Cellular signalling.

Muscarinic M2 receptors mediate transactivation of EGF receptor through Fyn kinase and without matrix metalloproteases.

C. Valkova, C. Liebmann, S. Drube, 2006, Cellular signalling.

Cross Talk between -Adrenergic and Bradykinin B2 Receptors Results in Cooperative Regulation of Cyclic AMP Accumulation and Mitogen-Activated Protein Kinase Activity

C. Liebmann, S. Hanke, D. Groll, 2001 .

Cross Talk between-Adrenergic and Bradykinin B 2 Receptors Results in Cooperative Regulation of Cyclic AMP Accumulation and Mitogen-Activated Protein Kinase Activity

B. Nürnberg, C. Liebmann, S. Hanke, 2001 .

Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling.

F. Böhmer, C. Liebmann, 2000, Current medicinal chemistry.

Tyrosine Phosphorylation of Gsα and Inhibition of Bradykinin-induced Activation of the Cyclic AMP Pathway in A431 Cells by Epidermal Growth Factor Receptor*

R. Wetzker, B. Nürnberg, T. Steinmetzer, 1996, The Journal of Biological Chemistry.

Protein kinase Cε may act as EGF-inducible scaffold protein for phospholipase Cγ1

C. Valkova, D. Imhof, C. Liebmann, 2007 .

Allosteric modulation by protein kinase Cε leads to modified responses of EGF receptor towards tyrosine kinase inhibitors.

C. Liebmann, Simona Weisheit, 2012, Cellular signalling.

Activation by Tyrosine Phosphorylation as a Prerequisite for Protein Kinase Cζ to Mediate Epidermal Growth Factor Receptor Signaling to ERK

C. Valkova, D. Imhof, C. Liebmann, 2010, Molecular Cancer Research.

Activated EGF receptor may balance ERK-inhibitory network signalling pathways.

C. Valkova, C. Liebmann, S. Drube, 2006, Cellular signalling.

PKCε acts as negative allosteric modulator of EGF receptor signalling.

C. Schäfer, A. Berndt, C. Liebmann, 2011, Cellular signalling.

A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer

G. Schneider, R. Stauber, S. Knauer, 2011, Oncotarget.

Bradykinin action in the rat duodenum: receptor binding and influence on the cyclic AMP system.

S. Reissmann, P. Robberecht, C. Liebmann, 1987, Biomedica biochimica acta.

Signaling effects of alpha-thrombin and SFLLRN in rat glioma C6 cells.

H. Haller, C. Lindschau, A. Höer, 1996, Journal of neuroscience research.

Discrimination between bradykinin receptor subtypes in the rat uterus

C. Liebmann, S. Nawrath, 1994 .

Structure-activity relationships of cyclic β-casomorphin-5 analogues

P. Schiller, N. N. Chung, M. Schnittler, 1991, Peptides.

Opiate receptor binding affinities of some D-amino acid substituted β-casomorphin analogs

K. Neubert, C. Liebmann, M. Szücs, 1986, Peptides.

Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.

R. Bossé, E. Escher, C. Liebmann, 1994, Molecular pharmacology.

Affinity cross-linking of bradykinin B2 receptors in guinea pig ileum membranes.

C. Liebmann, A. Graness, 1994, European journal of pharmacology.

G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts.

Claus Liebmann, C. Liebmann, 2004, Current pharmaceutical design.

Expression and Functional Characterization of a pHis-Tagged Human Bradykinin B2 Receptor in COS-7Cells

S. Reissmann, H. Passow, R. Kaufmann, 2000 .

Intramolecular signal transduction by the bradykinin B2 receptor.

S. Reissmann, C. Liebmann, Sylvia Mueller, 2002, International immunopharmacology.

Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.

R. Wetzker, C Liebmann, A Graness, 1996, The Biochemical journal.

Myofibroblasts have an impact on expression, dimerization and signaling of different ErbB receptors in OSCC cells

C. Valkova, A. Berndt, C. Kosan, 2017, Journal of receptor and signal transduction research.